Sirolimus for patients with progressive epithelioid hemangioendothelioma

Cancer. 2021 Feb 15;127(4):504-506. doi: 10.1002/cncr.33246. Epub 2020 Oct 27.

Abstract

Epithelioid hemangioendothelioma is an ultrarare soft tissue sarcoma with limited literature to guide treatment. The results from a robust retrospective cohort study support the use of sirolimus for patients who have multifocal epithelioid hemangioendothelioma without serosal effusion.

Keywords: EHE; chemotherapy; epitheliod hamangioendothelioma; sarcoma; sirolimus.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adult
  • Child
  • Hemangioendothelioma, Epithelioid* / drug therapy
  • Humans
  • Sarcoma*
  • Sirolimus

Substances

  • Sirolimus